The label expansion could help J&J establish Tremfya as a successor to Stelara, which is now facing a growing biosimilar ...

Learn about different types of eczema, symptoms, treatment options, and how to differentiate from other skin conditions.

Bio-Thera and Dr. Reddy's partner for biosimilar commercialization in Southeast Asia, expanding access to affordable ...

Generally speaking, biologics are typically prescribed when first-line treatments haven't worked. There are no treatments that will cure psoriasis overnight, but it can help to apply an ointment-based ...

Rheumatologists and cardiologists have long co-managed patients out of necessity and without much formal collaboration or ...

These names in the biotech sector are seeing a substantial increase in search activity today, as determined by InvestingChannel. They include: ...

Following big announcements from Lilly and Merck, J&J is pledging $55 billion over the next four years to open new plants.

Biologic medical therapies, or biologics, are an important type of treatment for Crohn ... targets interleukin 12 and 23 to help manage Crohn’s disease. Approved in 2016 for Crohn's disease Also ...

In a retrospective cohort study, ustekinumab and guselkumab show trends toward lower risk for herpes zoster in patients with ...

Risankizumab was associated with more significant improvements among patients with plaque psoriasis when compared with other biologic therapies.